Relationships and Synergistic Effects of Body Mass Index and Blood Glucose Marker on the Ankle-Brachial Index in Adult With Type 2 Diabetes Mellitus: A Cross-Sectional Study.
{"title":"Relationships and Synergistic Effects of Body Mass Index and Blood Glucose Marker on the Ankle-Brachial Index in Adult With Type 2 Diabetes Mellitus: A Cross-Sectional Study.","authors":"Siti Fadlilah, Herlin Ajeng Nurrahma, Sumarni Sumarni, Jia Ruey Tsai, Wei-Jun Wang, Hsiu Ting Tsai","doi":"10.1111/nhs.70055","DOIUrl":null,"url":null,"abstract":"<p><p>This study aimed to identify the independent and synergistic effects of body mass index, fasting blood glucose, and hemoglobin A1c on ankle-brachial index in type 2 diabetes mellitus. This cross-sectional study involved 1096 participants who were measured using questionnaires, a digital scale, and a height measurement device. Blood marker was examined using fasting venous blood. The ankle-brachial index was measured using Doppler ultrasound. A multinomial logistic regression was applied for adjusting confounders. Participants who were obese significantly increased 2.12- and 1.86-fold risk of a low and a high ankle-brachial index (p < 0.05), respectively. Participants with abnormal fasting blood glucose significantly increased 1.79- and 2.05-fold risk of a low and a high ankle-brachial index (p < 0.05). Participants with hemoglobin A1c > 6.5% significantly increased 1.71- and 1.76-fold risk of a low and a high ankle-brachial index (p < 0.05), respectively. Participants with abnormalities for all three indices synergistically increased 12.31- and 5.31-fold risk of a low and a high ankle-brachial index (p < 0.001), respectively. Abnormal body mass index, fasting blood glucose, and hemoglobin A1c readings significantly, independently, and synergistically increased the risk of an abnormal ankle-brachial index.</p>","PeriodicalId":49730,"journal":{"name":"Nursing & Health Sciences","volume":"27 1","pages":"e70055"},"PeriodicalIF":1.6000,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nursing & Health Sciences","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1111/nhs.70055","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"NURSING","Score":null,"Total":0}
引用次数: 0
Abstract
This study aimed to identify the independent and synergistic effects of body mass index, fasting blood glucose, and hemoglobin A1c on ankle-brachial index in type 2 diabetes mellitus. This cross-sectional study involved 1096 participants who were measured using questionnaires, a digital scale, and a height measurement device. Blood marker was examined using fasting venous blood. The ankle-brachial index was measured using Doppler ultrasound. A multinomial logistic regression was applied for adjusting confounders. Participants who were obese significantly increased 2.12- and 1.86-fold risk of a low and a high ankle-brachial index (p < 0.05), respectively. Participants with abnormal fasting blood glucose significantly increased 1.79- and 2.05-fold risk of a low and a high ankle-brachial index (p < 0.05). Participants with hemoglobin A1c > 6.5% significantly increased 1.71- and 1.76-fold risk of a low and a high ankle-brachial index (p < 0.05), respectively. Participants with abnormalities for all three indices synergistically increased 12.31- and 5.31-fold risk of a low and a high ankle-brachial index (p < 0.001), respectively. Abnormal body mass index, fasting blood glucose, and hemoglobin A1c readings significantly, independently, and synergistically increased the risk of an abnormal ankle-brachial index.
期刊介绍:
NHS has a multidisciplinary focus and broad scope and a particular focus on the translation of research into clinical practice, inter-disciplinary and multidisciplinary work, primary health care, health promotion, health education, management of communicable and non-communicable diseases, implementation of technological innovations and inclusive multicultural approaches to health services and care.